Clinical Trials Browser

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT04322006 2026-05-13

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Phase 1/2 Completed

225 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04687761 2026-05-13

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Phase 1/2 Completed

113 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03758287 2026-05-12

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Phase 1/2 Completed

108 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04902872 2026-05-12

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Phase 1/2 Completed

69 enrolled

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT01171898 2026-05-11

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Completed

127 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT03767582 2026-05-11

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Phase 1/2 Completed

22 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Phase 1/2 Completed

30 enrolled 16 charts

Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

NCT04505826 2026-05-11

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

Phase 1/2 Completed

153 enrolled 21 charts

Breast

Hormone Receptor Positive Breast Carcinoma

NCT06668987 2026-05-11

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma

Phase 1/2 Completed

10 enrolled

CNS

Meningioma

NCT02535533 2026-05-06

SLM + Axitinib for Clear Cell RCC

Phase 1/2 Completed

45 enrolled 18 charts

Genitourinary

Kidney Neoplasms

NCT05532722 2026-05-06

ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Phase 1/2 Completed

21 enrolled

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT03035331 2026-05-04

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Phase 1/2 Completed

11 enrolled 12 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04083534 2026-05-04

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Phase 1/2 Completed

43 enrolled

Plasma cell

Multiple Myeloma

NCT01625234 2026-04-30

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

Phase 1/2 Completed

131 enrolled 22 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03802071 2026-04-30

A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

44 enrolled

Sarcoma

NCT03872778 2026-04-30

NeoRay

Phase 1/2 Completed

35 enrolled

Tumor-Agnostic

Neoplasms

NCT03068819 2026-04-24

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Phase 1/2 Completed

62 enrolled 29 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06059014 2026-04-24

PRadR

Phase 1/2 Completed

6 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT02661542 2026-04-23

Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

Phase 1/2 Completed

106 enrolled 29 charts

Lymphoid

Lymphoma

NCT04216953 2026-04-23

COTESARC

Phase 1/2 Completed

229 enrolled

Sarcoma

NCT05683834 2026-04-22

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Phase 1/2 Completed

25 enrolled

Herpes Simplex, Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05975073 2026-04-22

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Phase 1/2 Completed

53 enrolled

Tumor-Agnostic

Neoplasms

NCT06614140 2026-04-22

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Phase 1/2 Completed

8 enrolled

Tumor-Agnostic

Neoplasms

NCT01802632 2026-04-20

AURA

Phase 1/2 Completed

603 enrolled 17 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT05189093 2026-04-20

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

Phase 1/2 Completed

48 enrolled

Lymphoid

Lymphoma

NCT04174716 2026-04-17

VASTUS

Phase 1/2 Completed

108 enrolled

Other solid neoplasm

Solid Tumors

NCT05282459 2026-04-17

Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation

Phase 1/2 Completed

17 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid

NCT04072952 2026-04-15

mBC

Phase 1/2 Completed

217 enrolled

Breast

Breast Neoplasms

NCT05304936 2026-04-15

HCW9218 for Advanced Pancreatic Cancer

Phase 1/2 Completed

21 enrolled

Gastrointestinal

Advanced Pancreatic Carcinoma

NCT02866747 2026-04-14

STERIMGLI

Phase 1/2 Completed

108 enrolled

CNS

Glioblastoma

NCT07529613 2026-04-14

T-DXd_HER2Low

Phase 1/2 Completed

30 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02625480 2026-04-09

ZUMA-4

Phase 1/2 Completed

95 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

Clinical Trials

ENDOLA

TRIFOUR

A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer

Vaccination With Flt3L, Radiation, and Poly-ICLC

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

KEYNOTE145

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma

SLM + Axitinib for Clear Cell RCC

ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma

NeoRay

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

PRadR

Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

COTESARC

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

AURA

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

VASTUS

Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation

mBC

HCW9218 for Advanced Pancreatic Cancer

STERIMGLI

T-DXd_HER2Low

ZUMA-4